Recent developments with Kymera Therapeutics Inc (KYMR) have led to the company’s beta value being reach 2.18 cents.
On Tuesday, Kymera Therapeutics Inc (NASDAQ: KYMR) opened lower -5.58% from the last session, before settling in for the closing price of $33.70. Price fluctuations